Siga Technologies SIGA
NASDAQ SIGA
$3.09 -0.11 (-3.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Siga Technologies (SIGA) Non Operating Interest Expenses (2012 - 2020)

Siga Technologies' (SIGA) quarterly Non Operating Interest Expenses came in at $3.0 million in Q1 2020, down 23.21% on a YoY basis from $3.9 million in Q2 2019, and down 22.61% quarter-over-quarter from $3.9 million in Q4 2019.

Analysis

Siga Technologies (SIGA) Non Operating Interest Expenses (2012 - 2020) Analysis & Trends

Siga Technologies (SIGA) has reported Non Operating Interest Expenses for 9 consecutive years, with $3.0 million the latest figure, recorded in Q1 2020.

  • For the quarter ending Q1 2020, Non Operating Interest Expenses fell 23.21% year-over-year to $3.0 million; the trailing twelve-month figure through Dec 2020 stood at $3.0 million (down 80.87% YoY), and the FY2020 full-year result was $3.0 million, down 80.87% from the prior year.
  • Non Operating Interest Expenses declined to $3.0 million in Q1 2020 per SIGA's latest filing, from $3.9 million in the prior quarter.
  • Across five years, Non Operating Interest Expenses topped out at $4.0 million in Q3 2019 and bottomed at $10214.0 in Q2 2016.
  • Historically, Non Operating Interest Expenses has averaged $3.2 million across 5 years, with a median of $3.8 million in 2017.
  • The sharpest annual moves came in 2016 and 2017: Non Operating Interest Expenses dropped 23.29% in 2016, then soared 35659.7% in 2017.
  • Over 5 years, Non Operating Interest Expenses stood at $2.3 million in 2016, then surged by 64.25% to $3.8 million in 2017, then advanced by 5.31% to $4.0 million in 2018, then decreased by 1.61% to $3.9 million in 2019, then slipped by 22.61% to $3.0 million in 2020.
  • According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $3.0 million, $3.9 million, and $4.0 million for Q1 2020, Q4 2019, and Q3 2019 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 281.00 Mn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn -
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn -
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn -462.00 Mn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn -333.60 Mn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 23.78 Mn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 582,000.00
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 2.90 Mn
10 Siga Technologies 220.19 Mn 65.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 3.02 Mn
Dec 31, 2019 3.90 Mn
Sep 30, 2019 3.97 Mn
Jun 30, 2019 3.97 Mn
Mar 31, 2019 3.93 Mn
Dec 31, 2018 3.96 Mn
Sep 30, 2018 3.92 Mn
Jun 30, 2018 3.84 Mn
Mar 31, 2018 3.75 Mn
Dec 31, 2017 3.76 Mn
Sep 30, 2017 3.74 Mn
Jun 30, 2017 3.65 Mn
Mar 31, 2017 3.61 Mn
Dec 31, 2016 2.29 Mn
Sep 30, 2016 94,776.00
Jun 30, 2016 10,214.00
Jun 30, 2015 13,315.00
Mar 31, 2015 253,412.00
Dec 31, 2014 86,223.00
Sep 30, 2014 105,149.00